Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 56.33
-0.33 (-0.58%)
Jun 6, 2025, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 33.74 billion as of June 6, 2025. Its market cap has increased by 13.43% in one year.
Market Cap
33.74B
Enterprise Value
31.39B
Revenue
3.47B
Ranking
n/a
PE Ratio
39.89
Stock Price
56.33
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 33.74B, a decrease of -7.75%. That is a compound annual growth rate of -1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 33.74B | 28.13% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 356.56B |
| Shenzhen Mindray Bio-Medical Electronics | 284.57B |
| WuXi AppTec | 184.47B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.65B |
| Sichuan Biokin Pharmaceutical | 122.55B |
| Aier Eye Hospital Group | 117.29B |
| Shanghai United Imaging Healthcare | 116.46B |
| Yunnan Baiyao Group Co.,Ltd | 100.99B |